http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105412120-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0d44338a9983e0302c286cb9d319ff9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
filingDate 2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_685253980351b754f8ecf6867157fabf
publicationDate 2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105412120-A
titleOfInvention Application of Epishionol in preparing drugs for treating lung cancer
abstract The invention discloses the application of Epishionol in preparing drugs for treating lung cancer and belongs to the technical field of novel application of drugs. The compound has high anti-lung-cancer activity and can be used for preparing drugs for treating lung cancer. Epishionol can remarkably restrain in-vitro cultured non-small cell lung cancer cells A549, large cell lung cancer cells NCI-H460, lung squamous carcinoma cells HTB-8 and human lung epidermoid carcinoma cells QG-5, and has a small restraining effect on human normal hepatic cells LO2 and peripheral blood lymphocytes, and remarkable selectivity is realized. The application of Epishionol in preparing drugs for treating lung cancer is disclosed for the first time, a novel framework type is adopted, and the lung cancer cell inhibitory activity of Epishionol is surprisingly high.
priorityDate 2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15378657
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426717729

Total number of triples: 19.